乌鸦传媒

<乌鸦传媒 class='mpt-top_cat_title'>Meeting Coverage >

ESC

<乌鸦传媒>Stopping Beta-Blockers Did Not Go as Planned for Long-Time Users

No benefit to beta-blocker interruption among MI survivors using them for secondary prevention

<乌鸦传媒>Wegovy Protects Against Deadly COVID Cases

Non-cardiovascular benefits observed in SELECT trial

<乌鸦传媒>No Aspirin After PCI? Extended P2Y12 Monotherapy? Trials Weigh In

Two trials read out, but generalizability is the question

<乌鸦传媒>Cancer Therapy's Lower-Limb Blood Clots Better Treated With Long Anticoagulation

A year of DOAC therapy did not result in significantly more bleeds in ONCO DVT trial

<乌鸦传媒>Novel Amyloid Drug Improves Mid-Term Outcomes in ATTR Cardiomyopathy

Pivotal trial "suggests the tantalizing possibility of genuine clinical improvement"

<乌鸦传媒>Compound in Beetroot Juice Fends Off Contrast-Induced AKI

"Provocative" results for inorganic nitrate pill shown in NITRATE-CIN trial

<乌鸦传媒>Less Atrial Pacing Doesn't Cut Afib in Sinus Node Dysfunction

Trial debunks strategy for higher-risk group

<乌鸦传媒>Immune Suppressant Stumbles for Acute Myocarditis in Early Data

Phase II trial might not end the story for anti-inflammatory approach, though

<乌鸦传媒>STEMI Complete Revascularization: No Point in Waiting

MULTISTARS AMI trial helps answer the timing question in multivessel disease treatment

<乌鸦传媒>Rush to DOACs Spells Trouble for Frail Warfarin Users

Lower bleeding risk of new blood thinners did not extend to this older subgroup

<乌鸦传媒>Ambulance Routing Might Not Matter After Cardiac Arrest

Trial in best-case scenario setting shows sending patients to specialty centers doesn't help

<乌鸦传媒>Pulsed Field Ablation Measures Up in Head-to-Head Trial

Novel catheters on par with thermal ablation, but do they meet the early high hopes?

<乌鸦传媒>Afib Ablation Exceeds Expectations in Sickest Heart Failure Patients

Death and surgeries delayed in end-stage heart failure

<乌鸦传媒>CRT-D Upgrade Suits Patients With Pacing-Related Heart Failure

BUDAPEST-CRT Upgrade is the first major trial on upgrade strategy

<乌鸦传媒>Trial: ECMO Doesn't Save Lives in Cardiogenic Shock

ECLS-SHOCK trial challenges current practice, guidelines

<乌鸦传媒>Complete PCI Better for Older MI Patients Too

Trial affirms advantage over culprit-lesion-only stenting in those ages 75 and up

<乌鸦传媒>Iron Infusions Narrowly Miss the Mark for Clinical Benefit in Heart Failure

Hard endpoints do not favor IV ferric carboxymaltose in well-powered HEART-FID

<乌鸦传媒>Colchicine Stumbles for Protecting the Heart From Thoracic Surgery

Trial meets only post hoc endpoints in extending protection to non-cardiac surgeries

<乌鸦传媒>SGLT2 Inhibitors, Rapid Titration, IV Iron Get a Boost in New European HF Guideline

Other recommendations also released for endocarditis, cardiomyopathies, ACS, and more

<乌鸦传媒>Wegovy Reduces Heavy Symptom Burden of Obesity-Related Heart Failure

Heart failure with preserved ejection fraction and obesity becoming more common

<乌鸦传媒>Subclinical Afib Caught on Cardiac Devices Might Be Better Left Alone

Trial shows no stroke reduction with DOAC at the cost of more adverse events

<乌鸦传媒>Full-Dose Anticoagulation Cuts VTE in Severe COVID-19

But is it worthwhile without a mortality benefit? Trials present complex picture

<乌鸦传媒>Milestone Reached for SGLT2 Inhibitor Aimed at Heart Attack Population

Good signals in people with large acute MIs at risk of developing heart failure

<乌鸦传媒>P2Y12 Inhibitors May Be the Better Option for Secondary Prevention in CAD

Meta-analysis challenges central role of aspirin, researcher says

<乌鸦传媒>Muscle Pain in Statin Patients Is Usually Not Caused by the Drug

A meta-analysis pointed to a low incidence of drug-related pain

<乌鸦传媒>Novel Factor XIa Inhibitors Show Promise for Bleeding Risk

Preventing ischemic events is a less clear benefit

<乌鸦传媒>Transradial Access for Heart Procedures Saves Lives in Most Definitive Study Yet

Approach beats coronary access through the thigh

<乌鸦传媒>Pendulum Swings Back for FFR-Guided Complete Revascularization

Modality helps avoid unnecessary intervention in heart attack patients with multivessel disease

<乌鸦传媒>Doubling Up on Heart Drugs May Delay Aortic Damage From Marfan Syndrome

Meta-analysis settles the confusion around angiotensin receptor blockers

<乌鸦传媒>Perfusion Tests Comparable as Second-Line Diagnostic for Chest Pain

Head-to-head trial finds "interchangeable" accuracy

<乌鸦传媒>Routine Stress Testing Didn't Offer Benefits to High-Risk Patients Post-PCI

South Korean trial showed no improvement in clinical outcomes at 2 years

<乌鸦传媒>High-Dose Flu Vaccine Promising for Mortality Benefits in Older Adults

Danish pilot study lays groundwork for larger trial looking for better CV outcomes

<乌鸦传媒>Extravascular ICD Gains Ground in Unfamiliar Territory

Inappropriate shocks among early challenges of device therapy under the sternum

<乌鸦传媒>Xarelto Risky in Rheumatic Heart Disease

Ischemic event prevention didn't pan out in INVICTUS trial

<乌鸦传媒>Finally, A Foundational Heart Failure Drug That Works Across the Spectrum of EF

SGLT2 inhibitor shines in landmark DELIVER trial

<乌鸦传媒>ADVOR Backs Add-On Acetazolamide for Cutting Congestion in Decompensated HF

Exclusion of patients on SGLT2 inhibitors was a major trial limitation, expert says

<乌鸦传媒>PCI Flops for Ischemic LV Dysfunction With Coronary Artery Disease

Randomized trial provides "definitive" evidence against revascularizing stable cases

<乌鸦传媒>Mass Cardiovascular Testing May Add Years for Some Men

Mixed results after the DANCAVAS program from Denmark

<乌鸦传媒>After Cardiac Arrest, No 'Best' Blood Pressure, Oxygen Target

BOX trial finds targets aiming to boost perfusion held no advantage

<乌鸦传媒>Breakfast or Bedtime BP Meds? Timing Doesn't Matter After All

TIME study supports taking antihypertensives whenever convenient

1